Retinal redox stress and remodeling in cardiometabolic syndrome and diabetes

Oxidative Medicine and Cellular Longevity

Volumn 3, Issue 6, 2010, Pages

  Yang, Ying ^a,c,d,e   Hayden, Melvin R ^b,d   Sowers, Susan ^d,e   Bagree, Sarika V ^b,d   Sowers, James R ^b,c,d,e  

^a 2nd People's Hospital of Yunnan Province   (China)

^b University of Missouri   (United States)

^c Physiology and Pharmacology   (United States)

^d Division of Endocrinology Diabetes Metabolism and Cardiovascular Disease   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiometabolic syndrome; Redox stress; Retina; Type 2 diabetes mellitus

Indexed keywords

BLOOD; ENDOTHELIAL CELLS; METABOLISM; OPHTHALMOLOGY; TISSUE; TOXICITY;

ADVANCED GLYCATION END PRODUCTS; BLOOD-RETINAL BARRIER; CARDIOMETABOLIC SYNDROME; DIABETIC RETINOPATHY; REACTIVE OXYGEN SPECIES; RETINA; TISSUE INFLAMMATION; TYPE 2 DIABETES MELLITUS;

EYE PROTECTION;

ADVANCED GLYCATION END PRODUCT; CYTOKINE; GROWTH FACTOR; HEXOSAMINE; POLYOL; PROTEIN KINASE C; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

BLINDNESS; BLOOD RETINA BARRIER; DIABETES MELLITUS; DIABETIC RETINOPATHY; DYSLIPIDEMIA; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; METABOLIC SYNDROME X; NONHUMAN; PERICYTE; REDOX STRESS; RETINA INJURY; REVIEW; UNITED STATES; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; RAT; RETINA; SWINE; ULTRASTRUCTURE;

RATTUS; SUS;

ANIMALS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; HUMANS; METABOLIC SYNDROME X; NITRIC OXIDE SYNTHASE; OXIDATION-REDUCTION; OXIDATIVE STRESS; RATS; REACTIVE OXYGEN SPECIES; RETINA; SWINE;

EID: 79951523106     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.3.6.14786     Document Type: Review

References (63)

1. Zhang X, Saaddine JB, Chou C, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States 2005-2008. JAMA 2010; 304:649-56.
2. Wong TY, Duncan BB, Golden SH, Klein R, Couper DJ, Klein BE, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci 2004; 45:2949-54. (Pubitemid 39121821)
3. Tikellis G, Anuradha S, Klein R, Wong TY. Association between physical activity measured during leisure activity and retinal microvascular signs: the Atherosclerosis Risk in Communities (ARIC) Study. Microcirculation 2010; 17:381-93.
4. Serne EH, Ijzerman RG, de Jongh RT, Stehouwer CD. Blood pressure and insulin resistance: role for microvascular function? Cardiovasc Res 2002; 53:271-6.
5. Hayden MR, Tyagi SC. Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy. Cardiovasc Diabetol 2002; 1:3.
6. DeMarco V, Johnson MS, Whaley-Connell AT, Sowers JR. Cytokine abnormalities in the etiology of the cardiometabolic syndrome. Curr Hyperten Rep 2010; 12:93-8.
7. Gardner TW, Sander B, Larsen ML, Kunselman A, Tenhave T, Lund-Andersen H, et al. An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial. Curr Eye Res 2006; 31:535-47. (Pubitemid 43884600)
8. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, Klein BE, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 2006; 141:446-55.
9. Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 1999; 13:23-30. (Pubitemid 29038271)
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-20. (Pubitemid 34000785)
11. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54:1615-25. (Pubitemid 40770750)
12. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, 3rd, et al. Diabetic retinopathy. Diabetes Care 1998; 21:143-56. (Pubitemid 28030402)
13. Miwa K, Nakamura J, Hamada Y, Naruse K, Nakashima E, Kato K, et al. The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res Clin Pract 2003; 60:1-9. (Pubitemid 36299247)
14. Stitt AW. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp Mol Pathol 2003; 75:95-108. (Pubitemid 36798117)
15. Kowluru R, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex and effects of antioxidant therapy. Curr Eye Res 1994; 13:891-6.
16. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J Clin Invest 1998; 101:1219-24. (Pubitemid 28145237)
17. van Reyk DM, Gillies MC, Davies MJ. The retina: oxidative stress and diabetes. Redox Rep 2003; 8:187-92. (Pubitemid 37236230)
18. Hayden MR, Whaley-Connell A, Sowers JR. Renal redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus and diabetic nephropathy: paying homage to the podocyte. Am J Nephrol 2005; 25:553-69. (Pubitemid 41819029)
19. Ejaz S, Chekarova I, Ejaz A, Sohail A, Lim CW. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes Metab 2008; 10:53-63. (Pubitemid 350302431)
20. Murata M, Ohta N, Fujisawa S, Tsai JY, Sato S, Akagi Y, et al. Selective pericyte degeneration in the retinal capillaries of galactose-fed dogs results from apoptosis linked to aldose reductase-catalyzed galactitol accumulation. J Diabetes Complications 2002; 16:363-70.
21. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 1994; 269:9889-97. (Pubitemid 24196599)
22. Yang YS, Danis RP, Peterson RG, Dolan PL, Wu YO. Acarbose partially inhibits microvascular retinopathy in the Zucker Diabetic Fatty rat (SDF/Gmi-fa). J Ocul Pharmacol Ther 2000; 16:471-9.
23. van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003; 121:245-51. (Pubitemid 36184039)
24. Henricsson M, Nystrom L, Blohme G, Ostman J, Kullberg C, Svensson M, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care 2003; 26:349-54. (Pubitemid 36929054)
25. Zhang L, Krzentowski G, Albert A, Lefebvre PJ. Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001; 24:1275-9. (Pubitemid 33716411)
26. Tapp RJ, Shaw JE, Harper CA, de Courten MP, Balkau B, McCarty DJ, et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 2003; 26:1731-7. (Pubitemid 36929112)
27. Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 1999; 34:146-54.
28. Fan F, Stoeltzing O, Liu W, McCarty MF, Jung YD, Reinmuth N, et al. Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells. Cancer Res 2004; 64:3186-90. (Pubitemid 38581421)
29. Ibrahim AS, El-Shishtawy MM, Peria A Jr, Liou GI. Genistein attenuates retinal inflammation associated with diabetes by targeting of microglial activation. Mol Vis 2010; 16:2033-42.
30. Amano S, Yamagishi S, Inagaki Y, Nakamura K, Takeuchi M, Inoue H, et al. Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes. Microvasc Res 2005; 69:45-55. (Pubitemid 40410467)
31. DeBosch BJ, Baur E, Deo BK, Hiraoka M, Kumagai AK. Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation. J Neurochem 2001; 77:1157-67. (Pubitemid 32467070)
32. Kato K, Osawa H, Ochi M, Kusunoki Y, Ebisui O, Ohno K, et al. Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy. Clin Endocrinol (Oxf) 2008; 68:442-9. (Pubitemid 351257865)
33. Ozturk BT, Bozkurt B, Kerimoglu H, Okka M, Kamis U, Gunduz K. Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness. Mol Vis 2009; 15:1906-14.
34. Yang Y, Andresen BT, Yang K, Zhang Y, Li X, Wang H. Association of vascular endothelial growth factor-634C/G polymorphism and diabetic retinopathy in type 2 diabetic Han Chinese. Exp Biol Med (Maywood) 2010; 235:1204-11.
35. Obrosova IG, Minchenko AG, Marinescu V, Fathallah L, Kennedy A, Stockert CM, et al. Antioxidants attenuate early upregulation of retinal vascular endothelial growth factor in streptozotocin-diabetic rats. Diabetologia 2001; 44:1102-10. (Pubitemid 32835501)
36. Becerra SP. Structure-function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv Exp Med Biol 1997; 425:223-37.
37. Spranger J, Osterhoff M, Reimann M, Mohlig M, Ristow M, Francis MK, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 2001; 50:2641-5. (Pubitemid 33733112)
38. Duh EJ, Yang HS, Suzuma I, Miyagi M, Youngman E, Mori K, et al. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 2002; 43:821-9. (Pubitemid 34184503)
39. Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 2002; 296:877-82.
40. Tsao YP, Ho TC, Chen SL, Cheng HC. Pigment epithelium-derived factor inhibits oxidative stress-induced cell death by activation of extracellular signal-regulated kinases in cultured retinal pigment epithelial cells. Life Sci 2006; 79:545-50.
41. Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese and type 2 diabetic subjects. Diabetes 2002; 51:2968-74.
42. Higuchi A, Ohashi K, Shibata R, Sono-Romanelli S, Walsh K, Ouchi N. Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism. Arterioscler Thromb Vasc Biol 2010; 30:46-53.
43. Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103:1057-63. (Pubitemid 32200177)
44. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999; 100:2473-6. (Pubitemid 30005109)
45. Fernandez-Real JM, Botas-Cervero P, Lopez-Bermano A, Casamitjana R, Funahashi T, Delgado E, et al. Adiponectin is independently associated with glycosylated haemoglobin. Eur J Endocrinol 2004; 150:201-5. (Pubitemid 38331903)
46. Ouedraogo R, Wu X, Xu SQ, Fuchsel L, Motoshima H, Mahadev K, et al. Adiponectin suppression of highglucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway. Diabetes 2006; 55:1840-6. (Pubitemid 44324141)
47. Motoshima H, Wu X, Mahadev K, Goldstein BJ. Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL. Biochem Biophys Res Commun 2004; 315:264-71. (Pubitemid 38183103)
48. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NFkappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102:1296-301.
49. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med 2006; 3:35-42. (Pubitemid 43078211)
50. Yamagishi S, Adachi H, Abe A, Yashiro T, Enomoto M, Furuki K, et al. Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. J Clin Endocrinol Metab 2006; 91:2447-50. (Pubitemid 43855041)
51. Yano K, Bauchat JR, Liimatta MB, Clemmons DR, Duan C. Downregulation of protein kinase C inhibits insulin-like growth factor I-induced vascular smooth muscle cell proliferation, migration and gene expression. Endocrinology 1999; 140:4622-32. (Pubitemid 30666129)
52. Kowluru RA, Odenbach S. Role of interleukin-1beta in the pathogenesis of diabetic retinopathy. Br J Ophthalmol 2004; 88:1343-7. (Pubitemid 39312984)
53. Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. L-arginine transport in retinas from streptozotocin diabetic rats; correlation with the level of IL-1β and NO synthase activity. Vision Research 1999; 39:3817-23. (Pubitemid 29378308)
54. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M. Activation of nuclear factorκB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002; 51:2241-8. (Pubitemid 34729031)
55. Dinarello CA, Donath MY, Mandrup-Poulsen T. Role of Il-1beta in type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 2010; 17:314-21.
56. Zhou L, Sun H, Xu J, Kang J. Level of vascular endothelial growth factor and interleukin-6 in aqueous humor in diabetic retinopathy patients. Yan Ke Xue-Bao 2010; 25:26-30.
57. Lee JH, Lee W, Kwon OH, Kim JH, Kwon OW, Kim KH, et al. Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy. Ann Clin Lab Sci 2006; 38:361-7.
58. Rojas M, Zhang W, Lee D, Romero M, Nguyen DT, Al-Shabrawey M, et al. Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Invest Ophthalmol Vis Sci 2010; 51:1709-18.
59. Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, et al. Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci USA 2007; 104:2425-30. (Pubitemid 46391413)
60. Oh IK, Kim SW, Oh J, Lee TS, Huh K. Inflammatory and angiogenic factors in the aqueous humor and the relationship to diabetic retinopathy. Curr Eye Res 2010; 35:1116-27.
61. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NFκB. Annu Rev Cell Biol 1994; 10:405-55.
62. Hayden MR, Yang Y, Habibi J, Sowers JR. Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes. Oxid Med Cell Longev 2010; 3; [Epub ahead of print].
63. Maiese K. Ringing in the New Year: new prospects for development, aging and longevity. Oxid Med Cell Longev 2010; 3:1.